Builders FirstSource
BLDR
$77.54
+6.04%
Builders FirstSource, Inc. is a leading manufacturer and supplier of building materials, operating in the U.S. construction industry. The company provides a comprehensive portfolio of structural and related products, including factory-built roof and floor trusses, wall panels, vinyl windows, custom millwork, and engineered wood, complemented by professional installation and turn-key framing services. As a key supplier to both large production builders and small custom homebuilders, the company's current investor narrative is dominated by its cyclical exposure to the housing market, with recent financial results showing a significant year-over-year revenue decline, reflecting the pressures of higher interest rates and a potential slowdown in residential construction activity. The debate centers on whether the stock's sharp decline represents a cyclical bottom or if further downside exists as the company navigates a challenging macro environment.…
BLDR
Builders FirstSource
$77.54
Investment Opinion: Should I buy BLDR Today?
Rating: Hold. The core thesis is that BLDR is a deeply cyclical stock caught in a downtrend, where near-term fundamental headwinds are balanced by a valuation that prices in significant pessimism, making it a high-risk, potentially high-reward turnaround bet that is not yet timely.
Supporting evidence includes a forward PE of 12.8x, which is reasonable if earnings recover as projected, and a low PS ratio of 0.75x, suggesting the stock is cheap on a sales basis. However, this is offset by severe fundamental deterioration: revenue declined -12.1% YoY, net margin compressed to 0.9%, and the stock has dramatically underperformed the market by -60.5% over the past year. The company's robust $853M in TTM free cash flow and manageable leverage (debt-to-equity of 1.30) are key strengths that provide downside protection.
The thesis would upgrade to a Buy if the forward PE compressed below 10x on sustained positive revenue growth or if quarterly gross margins demonstrate sequential stabilization above 30%. It would downgrade to a Sell if revenue growth decelerates further (below -15% YoY) or if the stock breaks decisively below the $65.10 support level on worsening macro data. Relative to its own depressed earnings and the uncertain cycle, the stock appears fairly valued to slightly undervalued, but the valuation is not yet compelling enough to overcome the clear negative momentum and earnings risk.
Sign up to view all
BLDR 12-Month Price Forecast
BLDR is a classic cyclical value trap versus deep value opportunity. The severe operational downturn is real and justifies the stock's -33.5% annual decline. However, the valuation (forward PE 12.8x) and balance sheet strength suggest the market has priced in a significant amount of bad news. The path forward is almost entirely dependent on the macro housing cycle, over which the company has little control. The neutral stance reflects this high uncertainty; the base case of a slow stabilization is most probable. The stance would upgrade to bullish on clear evidence of housing data inflecting positively and BLDR's gross margins stabilizing. It would turn bearish if the stock breaks $65 support or quarterly revenue declines accelerate beyond -15%.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Builders FirstSource's 12-month outlook, with a consensus price target around $100.80 and implied upside of +30.0% versus the current price.
Average Target
$100.80
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$62 - $101
Analyst target range
Analyst coverage for BLDR is limited, with only 3 analysts providing estimates, which is typical for a mid-cap cyclical stock and can lead to higher volatility and less efficient price discovery. The available data shows a consensus leaning towards a cautious stance, with recent institutional ratings including actions like 'Equal Weight' from Stephens & Co. and 'Hold' from Stifel, though there was an upgrade to 'Outperform' from RBC Capital in March 2026. The average revenue estimate for the coming period is $17.34 billion, with a range from $16.66 billion to $17.78 billion, indicating moderate expectations for a top-line recovery. The wide spread between the high and low revenue estimates underscores the high uncertainty surrounding the housing market's trajectory and the company's near-term performance. The lack of a published consensus price target in the data further highlights the limited and potentially divergent views among the few covering analysts, making it difficult to gauge a clear market sentiment or implied upside/downside from the current price.
Bulls vs Bears: BLDR Investment Factors
The bear case currently holds stronger evidence, anchored by the severe, quantifiable deterioration in fundamental performance: a -12.1% YoY revenue decline and an 83% plunge in net income. The stock's price action, with a -33.5% 1-year loss, directly reflects this operational contraction. However, the bull case is built on the premise that the market has overreacted, pricing in a deep cyclical trough as evidenced by a forward PE of 12.8x and a PS ratio of 0.75x, alongside a strong $853M free cash flow buffer. The single most important tension in the investment debate is the timing and magnitude of the housing cycle recovery. If interest rates stabilize or decline, spurring construction activity, BLDR's depressed valuation and operational leverage could drive a sharp rebound. Conversely, a prolonged downturn or further macro deterioration would validate the bearish fundamentals, potentially pushing the stock toward its 52-week low.
Bullish
- Strong Free Cash Flow Buffer: The company generated $853.3M in trailing twelve-month free cash flow, providing a significant financial cushion to weather the cyclical downturn. This robust cash generation supports the balance sheet, evidenced by a manageable debt-to-equity ratio of 1.30 and a healthy current ratio of 1.86.
- Valuation at Cyclical Lows: The stock trades at a trailing PS ratio of 0.75x, which is inexpensive on a sales basis and suggests substantial pessimism is priced in. Furthermore, the forward PE of 12.8x implies the market expects a meaningful earnings recovery, a significant discount to the trailing PE of 26.3x.
- Technical Oversold Condition: The stock is down 50% from its 52-week high of $151.03 and is trading near the bottom of its range, only ~15% above its 52-week low of $65.10. The 1-month price change of +0.56% suggests a potential for stabilization after a severe 6-month decline of -31.84%, indicating the selling pressure may be exhausted.
- Analyst Upgrade Amidst Pessimism: In March 2026, RBC Capital upgraded BLDR to 'Outperform', signaling a potential inflection point in sentiment. This stands in contrast to the broader analyst caution and limited coverage, suggesting some institutional conviction in a rebound.
Bearish
- Severe Cyclical Revenue and Profit Collapse: Q4 2025 revenue declined -12.1% YoY to $3.36B, and net income plummeted 83% YoY to $31.5M, with net margin collapsing to 0.9% from 5.0%. This sequential deterioration from Q2 2025's $4.23B revenue confirms a deep cyclical downturn is in progress, directly pressuring the stock.
- Elevated Volatility and Market Correlation: With a beta of 1.485, BLDR is ~50% more volatile than the market, which has amplified its downside, as seen in its -60.5% 1-year relative strength vs. the S&P 500. This high beta makes the stock a leveraged bet on the housing cycle, increasing risk during market downturns.
- Margin Compression Under Macro Pressure: Gross margin contracted to 29.8% in Q4 2025 from 32.3% a year ago, and operating income fell to $61.8M from $304.1M. This margin erosion, driven by pricing pressure and a weaker product mix, directly threatens profitability and the valuation multiple the market is willing to pay.
- Limited Analyst Coverage and High Uncertainty: Only 3 analysts cover the stock, leading to less efficient price discovery and higher volatility. The wide range in revenue estimates ($16.66B to $17.78B) underscores the high uncertainty around the housing market's trajectory and BLDR's near-term recovery.
BLDR Technical Analysis
The stock is in a pronounced and sustained downtrend, with a 1-year price change of -33.49% and a 6-month decline of -31.84%, significantly underperforming the broader market. As of the latest close at $74.98, the price is trading near the bottom of its 52-week range, approximately 50% above the 52-week low of $65.10 but a substantial 50% below the 52-week high of $151.03, indicating the stock is deeply oversold but has yet to find a durable floor. The recent 1-month price change of +0.56% offers a faint glimmer of stabilization after a severe sell-off, yet this minor bounce is dwarfed by the 3-month loss of -19.48%, confirming that any near-term momentum is weak and occurs within the context of a powerful bearish trend. The stock's beta of 1.485 confirms it is approximately 50% more volatile than the market, which has amplified its downside during the sector-wide sell-off, a critical factor for risk management. Key technical support is firmly established at the 52-week low of $65.10, while overhead resistance looms near the recent highs from early 2026 around $128; a decisive break below the $65 support could trigger another leg down, whereas a sustained move above the $90-$95 area would be the first sign of a potential trend reversal.
Beta
1.45
1.45x market volatility
Max Drawdown
-55.5%
Largest decline past year
52-Week Range
$65-$151
Price range past year
Annual Return
-31.4%
Cumulative gain past year
| Period | BLDR Return | S&P 500 |
|---|---|---|
| 1m | +0.2% | -0.1% |
| 3m | -14.9% | +9.0% |
| 6m | -29.4% | +7.0% |
| 1y | -31.4% | +22.9% |
| ytd | -25.9% | +8.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BLDR Fundamental Analysis
The company's revenue trajectory has turned sharply negative, with Q4 2025 revenue of $3.36 billion representing a year-over-year decline of -12.1%, a stark reversal from the growth seen in prior years. This contraction is evident across recent quarters, with revenue sequentially declining from $4.23 billion in Q2 2025 to the current level, signaling a significant cyclical slowdown in its core construction end-markets. Profitability has been severely impacted, with net income plummeting to $31.5 million in Q4 2025 from $190.2 million in the year-ago quarter, and the net margin compressing to a thin 0.9% from 5.0%. Gross margin for the quarter was 29.8%, down from 32.3% a year ago, reflecting pricing pressure and potentially unfavorable product mix as demand weakens. The balance sheet and cash flow position remains a relative strength, with a current ratio of 1.86 and a debt-to-equity ratio of 1.30, indicating manageable, albeit elevated, leverage. The company generated robust trailing twelve-month free cash flow of $853.3 million, providing a crucial buffer to navigate the downturn, and its return on equity of 10.0%, while down from prior peaks, suggests the business model can still generate acceptable returns even in a softer market.
Quarterly Revenue
$3.4B
2025-12
Revenue YoY Growth
-0.12%
YoY Comparison
Gross Margin
+0.29%
Latest Quarter
Free Cash Flow
$853284000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BLDR Overvalued?
Given the company's positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE ratio stands at 26.3x, which is elevated relative to the depressed earnings, while the forward PE of 12.8x suggests the market expects a significant earnings recovery in the coming year. This large gap implies investors are pricing in a cyclical rebound, betting that the current downturn is temporary. Compared to the broader Industrials/Construction sector, the stock's trailing PS ratio of 0.75x appears inexpensive on a sales basis, though this discount reflects the market's concern over collapsing profitability and the cyclical nature of the business. Historically, the stock's own valuation has compressed dramatically; its current trailing PE of 26.3x is near the lower end of its multi-year range, having fallen from levels above 90x in late 2025 when earnings were near a trough. Trading near historical valuation lows suggests the market has priced in substantial pessimism, creating a potential value opportunity if the company can stabilize its earnings, but it also signals that the current fundamentals are perceived as deteriorated.
PE
26.3x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 2x~90x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
12.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks center on the company's acute sensitivity to the housing cycle, as evidenced by the -12.1% YoY revenue decline and the 83% collapse in Q4 net income to $31.5M. While the balance sheet is stable with a debt-to-equity of 1.30, the severe margin compression—gross margin fell 250 bps to 29.8% and net margin shrank to 0.9%—creates earnings risk. The company's valuation (trailing PE of 26.3x) is elevated relative to these depressed earnings, creating a high bar for recovery; any further earnings disappointment could trigger multiple compression.
Market & Competitive Risks are dominated by macro sensitivity. The stock's beta of 1.485 confirms it is a leveraged play on the economy and housing market. The primary external threat is a prolonged period of elevated interest rates, which would continue to suppress residential construction activity and delay a fundamental recovery. Furthermore, trading at a forward PE of 12.8x implies the market expects a significant earnings rebound; if this recovery is slower than anticipated, the stock faces valuation compression risk relative to both its own history and sector peers.
The Worst-Case Scenario involves a deeper and more protracted housing recession than currently anticipated, leading to consecutive quarters of revenue declines exceeding -15% and net margins turning negative. This could be triggered by a hawkish Fed pivot or a broader economic recession. In this adverse scenario, the stock could re-test and break below its 52-week low of $65.10. Given the current price of $74.98, this implies a realistic downside of approximately -13%. A more severe drawdown towards the stock's maximum drawdown level of -55% from its high is possible in an extreme macroeconomic crisis, but the strong free cash flow generation provides a fundamental floor, making a total collapse less likely.
FAQ
The key risks are, in order of severity: 1) Macro/Cyclical Risk: BLDR's fortunes are tied directly to U.S. housing starts. Persistently high interest rates could prolong the downturn, leading to further revenue declines beyond the current -12.1% YoY. 2) Profitability Risk: Margins have collapsed, with net income down 83% YoY. Further gross margin compression from pricing pressure poses a direct threat to earnings. 3) Valuation/Multiple Risk: If the expected earnings rebound does not materialize in 2026, the forward PE of 12.8x could expand, leading to further price declines. 4) Volatility Risk: With a beta of 1.485, the stock is 50% more volatile than the market, amplifying losses during broader sell-offs, as seen in its -60.5% relative underperformance vs. the S&P 500.
The 12-month outlook for BLDR is highly uncertain and bifurcated, with a base case target range of $75-$95 (55% probability), a bull case of $105-$128 (25% probability), and a bear case of $60-$70 (20% probability). The base case, which is most likely, assumes a slow stabilization of the housing market where BLDR's revenue decline moderates and margins find a floor, leading to a range-bound stock. The bull case requires a swift housing recovery and margin expansion, while the bear case involves a deeper recession. The key assumption behind the base case forecast is that interest rates do not rise further, allowing housing activity to stabilize at current depressed levels, enabling BLDR's earnings to slowly recover towards analyst estimates.
BLDR's valuation sends mixed signals, making a clear verdict challenging. On one hand, the trailing PE of 26.3x appears elevated relative to its depressed current earnings. On the other, the forward PE of 12.8x suggests the market expects a substantial earnings recovery, and the Price-to-Sales ratio of 0.75x is inexpensive on a historical and sector-relative basis. The stock is trading near the bottom of its multi-year valuation range, indicating significant pessimism is priced in. Overall, the stock appears fairly valued to slightly undervalued for a cyclical recovery scenario, but it is not deeply undervalued given the ongoing earnings collapse. The valuation implies the market expects a moderate housing recovery in the next 12-18 months.
BLDR is a high-risk, speculative buy only suitable for investors with a strong conviction in a near-term housing market recovery and a high tolerance for volatility. The stock is down 33.5% over the past year and trades at a forward PE of 12.8x, which prices in significant earnings recovery. The strong free cash flow of $853M provides a buffer, but the severe fundamental deterioration (-12.1% revenue decline, -83% net income drop) presents clear risk. It could be a good buy for deep-value, contrarian investors willing to bet on a cyclical rebound, but it is not a good buy for conservative or short-term investors given the uncertain macro outlook and stock beta of 1.485.
BLDR is unsuitable for short-term trading due to its high beta (1.485) and direct exposure to volatile macroeconomic data and interest rate speculation. It is a long-term, cyclical investment best suited for a minimum 2-3 year horizon. This timeframe allows for the potential housing cycle to trough and recover, which is necessary for the company's fundamentals and stock price to rebound meaningfully. The lack of a dividend also removes any income incentive for short-term holders. Investors should be prepared for significant volatility and possess the patience to wait through potentially several more quarters of weak earnings before the long-term thesis plays out.